U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H14N2O4S2
Molecular Weight 326.391
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLIOTOXIN

SMILES

CN1C(=O)[C@]23CC4=CC=C[C@H](O)[C@H]4N2C(=O)[C@@]1(CO)SS3

InChI

InChIKey=FIVPIPIDMRVLAY-RBJBARPLSA-N
InChI=1S/C13H14N2O4S2/c1-14-10(18)12-5-7-3-2-4-8(17)9(7)15(12)11(19)13(14,6-16)21-20-12/h2-4,8-9,16-17H,5-6H2,1H3/t8-,9-,12+,13+/m0/s1

HIDE SMILES / InChI

Molecular Formula C13H14N2O4S2
Molecular Weight 326.391
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Gliotoxin is a potent crystalline antibiotic substance produced during the growth of the imperfect fungus Gliocladium jimbriatum. It is a natural mycotoxin with immunosuppressive and antimicrobial activity. Gliotoxin acts as NOTCH2 transactivation inhibitor in human neoplasias. It induced growth inhibition and apoptosis in multiple colorectal cancer cell lines with mutations of the Wnt signaling pathway. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with pronounced antitumor activity and favorable toxicity profile against breast cancer in vitro and in vivo.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
PKCdelta-mediated regulation of FLIP expression in human colon cancer cells.
2006-01-15
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.
2005-10
LaeA, a regulator of morphogenetic fungal virulence factors.
2005-09
Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation.
2005-09
Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
2005-08
Bioinformatic and expression analysis of the putative gliotoxin biosynthetic gene cluster of Aspergillus fumigatus.
2005-07-15
Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2).
2005-07
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner.
2005-07
Gliotoxin-induced cytotoxicity in three salmonid cell lines: cell death by apoptosis and necrosis.
2005-06
The mycotoxins citrinin and gliotoxin differentially affect production of the pro-inflammatory cytokines tumour necrosis factor-alpha and interleukin-6, and the anti-inflammatory cytokine interleukin-10.
2005-06
Aspergillus mycotoxins and their effect on the host.
2005-05
Anandamide induces necrosis in primary hepatic stellate cells.
2005-05
The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis.
2005-04
Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.
2005-03-15
Genes and molecules involved in Aspergillus fumigatus virulence.
2005-03
The ABC transporter gene in the sirodesmin biosynthetic gene cluster of Leptosphaeria maculans is not essential for sirodesmin production but facilitates self-protection.
2005-03
NF-kappaB inhibition accelerates apoptosis of bovine neutrophils.
2005-02-22
Fungal populations and mycotoxins in silage in Assiut and Sohag governorates in Egypt, with a special reference to characteristic Aspergilli toxins.
2005-02
TNF-alpha expression is transcriptionally regulated by RANK ligand.
2005-02
Production of gliotoxin on natural substrates by Trichoderma virens.
2005
Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit.
2004-12-10
Gliotoxins disrupt alanine metabolism and glutathione production in C6 glioma cells: a 13C NMR spectroscopic study.
2004-12
Directed biosynthesis of fluorinated pseurotin A, synerazol and gliotoxin.
2004-11
Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease.
2004-11
[Chemistry and biological effects of gliotoxin].
2004-11
Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss.
2004-10
Gliotoxin induces Mg2+ efflux from intact brain mitochondria.
2004-10
Effect and stability of gliotoxin, an Aspergillus fumigatus toxin, on in vitro rumen fermentation.
2004-09
The sirodesmin biosynthetic gene cluster of the plant pathogenic fungus Leptosphaeria maculans.
2004-09
Comparing a ciliate and a fish cell line for their sensitivity to several classes of toxicants by the novel application of multiwell filter plates to Tetrahymena.
2004-08-11
Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus.
2004-08
Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
2004-07-01
Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella.
2004-07
Cytotoxic substances from Aspergillus fumigatus in oxygenated or poorly oxygenated environment.
2004-07
Allergen activates peripheral blood eosinophil nuclear factor-kappaB to generate granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and interleukin-8.
2004-07
Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells.
2004-07
Anti-apoptotic effect of nerve growth factor is lost in congenital insensitivity to pain with anhidrosis (CIPA) B lymphocytes.
2004-05
Effect of aeration on gliotoxin production by Aspergillus fumigatus in its culture filtrate.
2004-04
Cytotoxicity of fungal metabolites to lepidopteran (Spodoptera frugiperda) cell line (SF-9).
2004-02
Detection of Aspergillus fumigatus mycotoxins: immunogen synthesis and immunoassay development.
2004-02
Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012.
2004-01-01
Effect of aeration on gliotoxin production by Aspergillus fumigatus in its culture filtrate.
2004-01
Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo.
2004
Influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in Jurkat T cells and human peripheral blood cells: anti-inflammatory and cytotoxic effects.
2003-12-01
Evidence for radiosensitizing by gliotoxin in HL-60 cells: implications for a role of NF-kappaB independent mechanisms.
2003-11-27
Pyrazino[1,2-a]indole-1,4-diones, simple analogues of gliotoxin, as selective inhibitors of geranylgeranyltransferase I.
2003-11-03
Concentration-dependent atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds.
2003-11
Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS.
2003-10
Accumulation of gliotoxin, a cytotoxic mycotoxin from Aspergillus fumigatus, in blue mussel (Mytilus edulis).
2003-09
Concentration-dependent preferences of absorptive and excretive transport cause atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds.
2002
Patents

Sample Use Guides

Rat: 3 mg/kg body wt
Route of Administration: Intraperitoneal
Culture-activated (14-day) rat Hepatic stellate cells (HSCs) and Culture-activated (24-day) human (H2) HSCs cells were treated for 4 hours with 1.5 umol/L gliotoxin. Rat and human HSCs resulted in striking morphologic alterations within 1 hour as judged by light microscopy. HSCs changed from a flattened fibroblastic phenotype with distinct cell-cell interfaces to a substratum-detached, rounded, and blebbed morphology.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:14:13 GMT 2025
Edited
by admin
on Mon Mar 31 22:14:13 GMT 2025
Record UNII
5L648PH06K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLIOTOXIN
MI  
Common Name English
NSC-102866
Preferred Name English
ASPERGILLIN
Common Name English
S. N.-12870
Code English
GLIOTOXIN [MI]
Common Name English
10H-3,10A-EPIDITHIOPYRAZINO(1,2-A)INDOLE-1,4-DIONE, 2,3,5A,6-TETRAHYDRO-6-HYDROXY-3-(HYDROXYMETHYL)-2-METHYL-, (3R,5AS,6S,10AR)-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C574
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
NCI_THESAURUS C747
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
Code System Code Type Description
WIKIPEDIA
Gliotoxin
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY
EPA CompTox
DTXSID60877179
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY
NSC
102866
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY
PUBCHEM
6223
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY
NCI_THESAURUS
C63680
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY NCIT
DAILYMED
5L648PH06K
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY
MERCK INDEX
m5746
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY Merck Index
FDA UNII
5L648PH06K
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY
CAS
67-99-2
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY
RXCUI
1661743
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY RxNorm
CHEBI
5385
Created by admin on Mon Mar 31 22:14:13 GMT 2025 , Edited by admin on Mon Mar 31 22:14:13 GMT 2025
PRIMARY